Home/Filings/4/0000921895-22-000663
4//SEC Filing

O'Connor Rita M 4

Accession 0000921895-22-000663

CIK 0001497504other

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 8:16 PM ET

Size

5.7 KB

Accession

0000921895-22-000663

Insider Transaction Report

Form 4
Period: 2022-02-22
O'Connor Rita M
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2022-02-22+110,000110,000 total
    Exercise: $4.99Exp: 2032-02-22Common Stock (110,000 underlying)
Footnotes (2)
  • [F1]Grant of stock options to the Reporting Person under the Issuer's 2018 Incentive Plan, as amended.
  • [F2]These stock options vest over a three year period as follows: 1/3 on the first anniversary of the grant date, 1/3 on the second anniversary of the grant date and 1/3 on the third anniversary of the grant date.

Issuer

PLx Pharma Inc.

CIK 0001497504

Entity typeother

Related Parties

1
  • filerCIK 0001389177

Filing Metadata

Form type
4
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 8:16 PM ET
Size
5.7 KB